Wachovia Downgrades OSI Pharmaceuticals

Analyst George Farmer sees competitive pressure for the company's Tarceva drug

Wachovia downgraded OSI Pharmaceuticals (OSIP ) to underperform from market perform.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.